<DOC>
	<DOCNO>NCT00550017</DOCNO>
	<brief_summary>The purpose clinical research study study safety Epofolate ( BMS-753493 ) patient advanced cancer ( Phase 1 portion ) determine whether Epofolate ( BMS-753493 ) shrink slow growth cancer patient advance ovarian , renal breast cancer ( Phase 2 portion )</brief_summary>
	<brief_title>A Phase 1/2 Study Epofolate ( BMS-753493 ) Subjects With Advanced Cancer ( Schedule 2 )</brief_title>
	<detailed_description />
	<criteria>Advanced cancer , exclude cancer blood Availability 10 tumor tissue slide Known brain metastasis Severe nerve damage Significant cardiovascular disease Inadequate blood count Inadequate liver kidney function Inadequate thyroid function uncontrolled thyroid disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>